Zoetis Appoints Gavin D.K. Hattersley to its Board of Directors
April 01 2024 - 4:30PM
Business Wire
Molson Coors’ President and Chief Executive
Officer brings valuable business leadership and global public
company experience to Zoetis Board
Zoetis Inc. (NYSE: ZTS) today announced the appointment of Gavin
D.K. Hattersley, President, Chief Executive Officer and Director of
Molson Coors Beverage Company, to its Board of Directors.
Mr. Hattersley brings global public company leadership and board
experience, including as a current Chief Executive Officer and
former Chief Financial Officer of Molson Coors, to the Zoetis
Board. He will serve on the Board’s Corporate Governance and
Sustainability Committee.
“Gavin Hattersley brings invaluable experience to our Board as
we continue to expand in key markets around the globe,” said
Kristin Peck, Chief Executive Officer of Zoetis. “His experience as
CEO of a public company will help Zoetis as we continue to advance
our vision to be the most trusted and valued animal health company,
shaping the future of animal care through our innovation, customer
obsession and purpose-driven colleagues.”
“We are pleased to welcome Gavin to Zoetis’ Board of Directors,
and we look forward to the contributions he will make as we
continue to advance Zoetis as the leader in animal health and
deliver innovation for our customers and the animals in their
care,” said Zoetis Board Chair Michael McCallister.
Mr. Hattersley has served as Molson Coors’ CEO since September
2019. Prior to his current position, Mr. Hattersley held various
positions within the company including Chief Executive Officer of
MillerCoors, the former U.S. division of Molson Coors, and as Chief
Financial Officer of Molson Coors’ global business. Prior to
joining the company, he held several financial management positions
with international businesses in the brewing and manufacturing
sectors, including SAB Limited and Barloworld Limited. Mr.
Hattersley holds an honors degree in accounting science and a
bachelor’s degree from the University of South Africa. As a member
of Molson Coors’ Board of Directors since 2019, Mr. Hattersley is
poised to bring wide-ranging expertise to the Zoetis Board, from
corporate development and P&L management to broad-based
financial acumen.
“I am incredibly grateful for the opportunity to join Zoetis’
Board of Directors at an exciting time for the company,” Hattersley
said. “Zoetis’ mission to lead the industry with best-in-class
animal care solutions, a diversified portfolio and a winning
company culture matches perfectly with my professional experience
and personal values, and I look forward to playing a role in
Zoetis’ bright future.”
With Mr. Hattersley’s appointment, Zoetis increased the size of
the Board from 12 to 13 members.
About Zoetis
As the world’s leading animal health company, Zoetis is driven
by a singular purpose: to nurture our world and humankind by
advancing care for animals. After innovating ways to predict,
prevent, detect, and treat animal illness for more than 70 years,
Zoetis continues to stand by those raising and caring for animals
worldwide – from veterinarians and pet owners to livestock farmers
and ranchers. The company’s leading portfolio and pipeline of
medicines, vaccines, diagnostics and technologies make a difference
in over 100 countries. A Fortune 500 company, Zoetis generated
revenue of $8.5 billion in 2023 with approximately 14,100
employees. For more information, visit www.zoetis.com.
ZTS-COR
ZTS-IR
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240401918431/en/
Media: Jenielle Alonso
1-973-945-4333 (o) jenielle.alonso@zoetis.com Laura Panza
1-973-975-5176 (o) laura.panza@zoetis.com Investors: Steve Frank 1-973-822-7141 (o)
steve.frank@zoetis.com Nick Soonthornchai 1-973-443-2792 (o)
nick.soonthornchai@zoetis.com
Zoetis (NYSE:ZTS)
Historical Stock Chart
From May 2024 to Jun 2024
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jun 2023 to Jun 2024